First Consulting Group Acquires Zorch, Inc.
18 Juni 2007 - 2:27PM
Business Wire
First Consulting Group, Inc., (FCG) (NASDAQ:FCGI) today announced
the acquisition of Zorch, Inc., a Salt Lake City, Utah based
company that has built a proprietary enterprise software solution
to provide regulated content management and collaboration for the
life sciences industry. The products and solutions by Zorch are
built entirely on the Microsoft Office Sharepoint Server platform,
and are designed to allow life sciences organizations to leverage
their existing Microsoft platform investments while capitalizing on
FCG�s product innovations and industry-leading best-practices. The
new offering acquired by FCG will be named FirstPoint�. Larry
Ferguson, chief executive officer of FCG, said, �We are very
excited to add the Zorch team to FCG and offer FirstPoint as a
solution to the life sciences market. FCG already has a
market-leading solution in FirstDoc�, a product that is used in 12
of the top 20 pharmaceutical companies and supports over 50,000 end
users. We believe there is a good opportunity to leverage FCG�s
strong brand name and experience in the life sciences market, and
the FirstPoint� product opens new opportunities for FCG in pharma
and biotech enterprises of all sizes.� Nigel Whitehead, senior vice
president of FCG and president of FCG Life Sciences, added, �This
acquisition gives us a leading edge platform to develop and grow
our life sciences customer base over the next several years.
FirstPoint offers a lower cost of ownership to deploy, maintain and
upgrade the solution; a simple and intuitive user interface, based
upon Microsoft Office and SharePoint; and simplified technology
architecture based upon a full Microsoft platform. As a result, the
FirstPoint product will be attractive to a global enterprise as
well as to small and mid-sized biotechnology companies seeking a
cost effective and efficient way to manage R&D, clinical and
regulatory content and submission management.� FCG will also
continue to extend its FirstDoc product for life sciences companies
to manage their regulated content. FirstDoc has been available for
nearly ten years. FCG is acquiring 100% of the outstanding equity
of Zorch for a lump sum cash payment. Zorch stockholders may earn
additional consideration for the sale if the business achieves
certain revenue and earnings targets during a four-year earn-out
period. Zorch will operate as part of FCG�s life sciences business
unit. The company will incur a one-time charge during the current
quarter in recognition of acquired in-process software research and
development expenses. The acquisition is expected to be neutral to
FCG earnings in the second half of 2007 and accretive thereafter.
About FCG FCG is a leading provider of outsourcing, consulting,
systems implementation and integration services and proprietary
software products for healthcare, pharmaceutical, and other life
sciences organizations throughout North America, Europe and Asia.
Through combinations of onsite, offsite and offshore outsourced
services, FCG provides low-cost, high-quality offerings to improve
its clients' performance. The firm's consulting and integration
services and proprietary software products increase clients'
operations effectiveness with and through information technology,
resulting in reduced costs, improved customer service, enhanced
quality of patient care, and more rapid introduction of new
pharmaceutical compounds. For more information about FCG, visit
www.fcg.com or call 800-345-0957. This release contains
forward-looking statements, including the potential of the markets
to be served by FCG as a result of the acquisition of Zorch. These
forward-looking statements involve known and unknown risks that may
cause each of FCG�s actual results and performance to be materially
different from the future results and performance stated or implied
by the forward-looking statements. Some of the risks that should be
considered include, among other things, (i) the ability of FCG to
successfully integrate Zorch�s operations and continue successful
development and roll-out of the FirstPoint solution; (ii) the
contributions of Zorch and FirstPoint to FCG�s overall operations;
(iii) whether the products and services described in this release
by FCG will achieve customer acceptance and provide the level of
functionality required to achieve such customer acceptance; (iv)
FCG�s ability to continue to develop and market both FirstPoint and
FirstDoc in the life sciences market; (v) FCG�s ability to provide
on-going support and maintenance for the products to its clients,
including maintaining the currency of the products in line with any
changes made to the underlying platforms on which the products are
operated; and (vi) other factors referenced in FCG�s most recent
Forms 10-K, 10-Q and other periodic reports filed with the
Securities and Exchange Commission. In light of the significant
uncertainties inherent in the forward-looking information included
in this release, the inclusion of such information should not be
regarded as a representation by FCG or any other person that FCG�s
objectives or plans will be achieved. FCG undertakes no obligation
to release publicly any revisions to any forward-looking statements
to reflect events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events.
First Consulting (NASDAQ:FCGI)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
First Consulting (NASDAQ:FCGI)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über First Consulting Grp (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere First Consulting Group, Inc. News-Artikel